Foamix Pharmaceuticals Ltd (NASDAQ:FOMX)

2.66
Delayed Data
As of 10:29am ET
 -0.01 / -0.37%
Today’s Change
2.40
Today|||52-Week Range
7.60
-25.91%
Year-to-Date

Today’s Trading

Previous close2.67
Today’s open2.67
Day’s range2.63 - 2.67
Volume10,634
Average volume (3 months)346,232
Market cap$148.0M
Data as of 10:29am ET, 05/22/2019

Growth & Valuation

Earnings growth (last year)+3.49%
Earnings growth (this year)+8.82%
Earnings growth (next 5 years)+2.32%
Revenue growth (last year)-2.02%
P/E ratioNM
Price/Sales43.60
Price/Book1.60

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...+0.13+1.85%
MTNBMatinas BioPharma Ho...-0.02-1.50%
--EcoGreen Internation...0.000.00%
XOMAXOMA Corp+0.04+0.24%
Data as of 10:42am ET, 05/22/2019

Financials

Next reporting dateAugust 7, 2019
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$3.6M
Annual profit (last year)-$74.2M
Net profit margin-2,062.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
David Domzalski
Chief Financial Officer &
Country Manager
Ilan Hadar
Corporate headquarters
Rehovot, Hamerkaz

Forecasts